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Abstract
Background: Fear of recurrence (FoR) is a major concern for patients following treatment for primary breast cancer,
affecting 60–99% of breast cancer survivors. Mini-AFTER is a brief intervention developed to address this fear, that
breast care nurses are ideally placed to deliver. However, their interest in delivering such an intervention is
unknown and crucial to its introduction. This study aims to assess the perceived feasibility of the Mini-AFTER
telephone intervention for implementation by breast care nurses to manage moderate levels of fear of recurrence
among breast cancer survivors.
Methods: A sequential explanatory mixed-methods design will be used, informed by normalisation process theory
(NPT). The design will be guided by the stages of NPT. Specifically, understanding and evaluating the process
(implementation) that would enable an intervention, such as the Mini-AFTER, not only to be operationalised and
normalised into everyday work (embedded) but also sustained in practice (integration). Phase 1: all members on
the UK Breast Cancer Care Nursing Network database (n = 905) will be emailed a link to a web-based survey,
designed to investigate how breast cancer survivors’ FoR is identified and managed within current services and
their willingness to deliver the Mini-AFTER. Phase 2: a purposive sample of respondents (n = 20) will be interviewed
to build upon the responses in phase 1 and explore breast care nurses’ individual views on the importance of
addressing fear of recurrence in their clinical consultations, interest in the Mini-AFTER intervention, the content,
skills required and challenges to deliver the intervention.
Discussion: This study will provide information about the willingness of breast care nurses (BCNs) to provide a
structured intervention to manage fear of recurrence. It will identify barriers and facilitators for effective delivery and
inform the future design of a larger trial of the Mini-AFTER intervention.
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Background
Despite continued reductions in breast cancer mortality,
60–99% of individuals treated for breast cancer live with
an ongoing fear that the cancer will recur [1–5], and for
which many seek help from health professionals. Fear of
recurrence (FoR) is rated as one of the top-ranking con-
cerns in breast cancer patients attending out-patient
clinics with 62% wishing to discuss this issue with their
clinician [6]. FoR may be exacerbated once treatment is
complete and can significantly increase healthcare en-
counters as survivors seek reassurance in distinguishing
between recurrence and treatment-related bodily changes
[7]. FoR can be understood as a natural response to a can-
cer diagnosis, experienced on a continuum from none to
very high. However, when severe, it can lead to distress,
difficulty in coping and is a predictor of poorer physical
health [8]. Prior work suggests health professionals lack
skills and/or confidence to adequately recognise or ad-
dress fears of breast cancer returning or progressing [1].
The Ottawa Fear of Recurrence Colloquium issued a
Delphi study-derived definition of FoR as ‘fear, worry, or
concern about the cancer returning or progressing’ ([9],
p.3267). High levels of FoR are characterised by exces-
sive checking, overvigilance, frequent intrusive thoughts,
poor sleep and anxiety [10], and can compromise quality
of life for several years following diagnosis and treatment
[4, 11–13]. Individuals experiencing this level of FoR
may require intensive specialist psychological support
[14]. Humphris et al. developed the AFTER intervention
for cancer patients with high levels of FoR [10, 15]. The
AFTER intervention is based on Leventhal’s Self-
Regulation Model which proposes that fears of illness
are triggered by sensations which people interpret as
symptoms [16, 17]. The acronym AFTER represents A =
Assessment, F = Family, T = Thoughts and feelings, E =
Examination and self-care and R = Returning of cancer
and review. The fear of recurrence 4-item scale (FCR4)
was used to determine the level of fear (score min 4 and
max 20). Three items refer to different aspects of anxiety
and worry about the cancer returning and the fourth
item invites a rating of frequency of ‘waves of strong
feelings about the cancer coming back’: a score of 10 on
this scale approximates to the 60th percentile and is de-
fined as moderate FoR; a score of 15 approximates to
the 90th percentile and equates to a high level of FoR
[10, 15]. The AFTER intervention is a manual-based
psychological treatment and comprises six face-to-face
sessions. Delivery is conducted by a suitably trained
psychologist or specialist cancer nurse. It has been
shown to benefit people with cancer such as head and
neck [10, 18]. It is generally accepted that early assess-
ment and brief structured intervention has the potential
to prevent symptoms of FoR worsening and to improve
QoL [19]. Evidence also suggests that cost savings could
be made if high FoR is effectively treated, because patients
with high FoR use more services or present later for tests
to identify recurrence [19, 20]. Hence, this focus on inter-
vening earlier, when FoR is at a moderate level, has led to
the development of a less intensive version of the AFTER
intervention, the Mini-AFTER intervention [21]. The rea-
soning for developing a brief version of the AFTER inter-
vention was based upon the following premises. First, a
preventive philosophy was considered beneficial, that is to
intervene prior to FoR rising to a high level. Second, this
preventative approach is strengthened by better under-
standing by health professionals of the impact of FoR on
the individual with cancer when it reaches high levels.
Third, BCNs are already working within all teams involved
in breast cancer treatment and follow-up, making them
well placed to deliver an intervention, and finally, the offer
of a brief intervention fits into a stepped-care service ap-
proach which adopts a FoR trajectory model, i.e. not a
simple one-off screen ‘test’ for FoR but rather a series of
interventions. This approach is supported by recent evi-
dence from the Netherlands on providing a stepped-care
approach to FoR [22].
The Mini-AFTER intervention has been developed spe-
cifically to reduce moderate FoR in breast cancer survivors
and is a single 30-min structured phone call designed to be
made by BCN. It covers four key aspects associated with
FoR: (1) ascertaining its significance and impact on cancer
survivors’ lives; (2) the nature of the symptom(s); (3) trig-
gers of FoR following treatment; (4) identifying potential
confidantes among family or friends, and/or if there are dif-
ficulties discussing FoR. Fear is legitimised by acknowledg-
ing these responses and discussing ways they can be
managed through relaxation procedures, normalising fears/
beliefs, setting goals to reduce self-checking and seeking
professional explanation and reassurance over unexplained
symptoms. The intervention has also been shown to signifi-
cantly reduce FoR [12, 23].
BCNs are highly skilled nurses who routinely provide
emotional and psychological support to those with breast
cancer [24] and were identified in the early development
of the Mini-AFTER as being best placed to deliver the
intervention [10]. Several studies have shown that nurse-
led telephone interventions for breast cancer follow-up
are feasible to deliver and they are associated with im-
proved overall QoL. None, however, have specifically fo-
cused on FoR as a major concern [25–29]. The ability and
confidence of BCNs to deal with this complex issue are
key to successful delivery of the Mini-AFTER. However, it
is unclear how ready and willing BCNs might be to deliver
this kind of brief intervention. Given the emotionally
laden nature of this particular problem and the concerns
that health professionals have about addressing this need,
it is not clear whether BCNs would be prepared to under-
take this role, or what kind of training might enable them
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to feel confident to deal with any problems that may arise.
There is a need, therefore, to understand if, and how,
breast cancer patients’ fears are currently assessed and
managed in practice, and what factors might contribute to
the successful implementation of the Mini-AFTER inter-
vention. This is a particularly important element of feasi-
bility testing before moving to a pilot study of this
intervention.
This protocol outlines a sequential explanatory mixed-
methods study, designed to assess the acceptability and de-
liverability of a brief telephone intervention (Mini-AFTER)
for the management of moderate fear of recurrence (FoR)
in breast cancer survivors based on the views of BCNs. The
findings from this study will inform the design of a larger
trial of the Mini-AFTER intervention.
Aims of study
The aim of this study is to determine the acceptability of
BCNs implementing the Mini-AFTER intervention to
identify and manage moderate levels of FoR among
breast cancer survivors. The study objectives are:
1. To capture current approaches used by BCNs to
identify and manage FoR
2. To understand the challenges and barriers for BCNs
in assessing and managing FoR
3. To explore any BCNs perceived challenges and
barriers to implementing the Mini-AFTER
intervention
4. To understand what would enable BCNs to
successfully implement the Mini-AFTER interven-
tion in practice
Methods
A mixed-methods sequential explanatory study has been
designed [30], involving the collection of data in two
consecutive phases (Table 1, adapted from Ivankova
et al. [31]). In the first phase, using a survey, quantitative
data will be collected and analysed to understand how
BCNs identify and address their patients’ FoR currently
and if there are any barriers to doing this in clinical
practice (objectives 1 and 2). The researchers will review
the results from phase 1 before proceeding to phase 2
and will build upon and elaborate further on areas of
importance to the overall study. An example of how the
researchers intend to do this will be to run an associ-
ation (as part of the statistical analysis) between the scale
values for the question ‘I always raise a discussion on
FoR vs. I only discuss FoR if the patient raises it’ ques-
tion with the question ‘Would you be interested in deliv-
ering the Mini-AFTER intervention in a future study?’
The interview schedule will include an area of question-
ing that can explore this further: i.e. explore BCNs’ indi-
vidual views on the importance of addressing FoR in
their clinical consultations, interest in the Mini-AFTER
intervention, the content, skills required and challenges
to deliver the intervention, ensuring objectives 3 and 4
are also fully addressed. Demographic data from the sur-
vey will guide the formation of the sample for the sec-
ond phase of qualitative interviews.
Normalisation process theory (NPT) will be used in this
study to provide a conceptual framework for this work [32].
NPT seeks to identify the component parts for understand-
ing and evaluating the process (implementation) that would
enable an intervention, such as the Mini-AFTER, not only
Table 1 Flowchart of the mixed-methods sequential explanatory design
Phase Procedure Product
Phase 1: data collection • Web-based survey • Numerical data
• Freetext responses
Phase 1: data analysis • Multi-level models
• Sensitivity analysis
• Coding free text responses
• Descriptive statistics
• Coded themes
Connecting Phase 1 and 2 • Purposive sampling frame determined by survey findings on
specific domains
• Develop interview questions to answer questions raised by
survey findings
• Interview sample
• Semi-structured interview schedule
Phase 2: data collection • Individual semi-structured phone interviews (n = 20)
• Verbatim transcription of interview audio recordings
• Interview transcripts
Phase 2: data analysis • Framework analysis • Thematic framework
• Indexed and charted data
• Mapping and interpretation of the data
Integration of Phase 1 and 2
results
• Interpretation of the survey data
• Refinement to implementation process
• Discussion
• Refinement of the Mini-AFTER intervention
• Revision of Mini-AFTER study design
• Feasible process for implementing Mini-AFTER in
BCN practice
• Future research
Adapted from Ivankova et al. [31]
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to be operationalised and normalised into everyday work
(embedded), but also sustained in practice (integration)
[33]. This theoretical approach focuses on the work of the
individual (in this study the BCN) and the group (support-
ing influence of the wider team) to enable an intervention
to be normalised. NPT comprises of four main components
(1) coherence (or sense-making); (2) cognitive participation
(or engagement); (3) collective action (work done to enable
the intervention to happen); and (4) reflexive monitoring
(formal and informal appraisal of the benefits and costs of
the intervention). The dynamic relationship between these
components is influenced by the wider context of the inter-
vention, e.g. organisational context, structures, social
norms, group processes, barriers, challenges and conven-
tions. Table 2 describes the four main NPT components in
more detail, maps the type of questions/topic areas that will
be explored against the framework and answer the objec-
tives of the overall study. Examples of how these topics
translated into the survey and/or interview questions are il-
lustrated. These results will determine the next steps, and if
a pilot RCT is indicated. If it is, it is likely to look at how
study recruitment (of nurses and patients), training model,
adherence to manual, patient response, and intraclass cor-
relation (ICC) estimation would be achieved.
Phase 1: web-based survey
Phase 1 will address objectives 1 and 2. Responses will
be collected from BCNs via a web-based survey to inves-
tigate the following feasibility domains [34]:
 Acceptability: e.g. How helpful are formal
assessment tools to assess patients for FoR?
 Demand: e.g. What is the estimated proportion of
patients who experience moderate and high levels of
FoR, and how is it currently managed in practice?
 Practicality: e.g. What support do BCNs currently
receive to fulfil their role and help patients deal with
psychological issues? What barriers do they encounter
using assessment tools in clinical practice?
 Adaptation: e.g. Do BCNs receiving training to deal
specifically with FoR?
 Integration: e.g. Would BCNs be interested in taking
part in a training course for Mini-AFTER and what
would this consist of?
The web-based survey will be conducted via the Bris-
tol Online Survey tool [35], which is fully compliant with
all UK data protection laws and is highly accessible
across different organisations.
Phase 1 sampling and recruitment
The survey link and participant information sheet will be
sent via email to members enrolled on Breast Cancer
Care’s Nursing Network database (n = 905). Breast Cancer
Care is a UK-based breast cancer charity. This organisa-
tion hosts a database of 905 health professionals working
directly with people affected by breast cancer, of which
65% are BCNs. A prerequisite of joining the network is
that a health professional must spend at least 50% of their
time working with people affected by breast cancer. This
number is consistent with data published by Macmillan
Cancer Support [36–39]. With no other national register
of BCNs in the UK, this route is the most direct way for
the research team to access the study population. How-
ever, further steps will be taken to increase awareness
among BCNs across the UK about the study through hos-
pital networks and regional BCN groups to enhance our
overall recruitment.
Eligibility criteria (being a BCN) will be detailed in the
email, participant information sheet and consent page.
Six weeks after the initial email, a reminder will appear
in an email bulletin, circulated by Breast Cancer Care.
The survey will be open for a period of 12 weeks.
Demographic data will be gathered about the age of
participants, number of years working with people af-
fected with breast cancer, number of years qualified, job
banding, clinical area they align with, i.e. surgery, oncol-
ogy, medical, highest level of clinical attainment, number
of BCNs in the respondents’ workplace, numbers of
newly diagnosed patients with breast cancer in their hos-
pital and respondents’ place of work.
Table 3 illustrates the flow of the topics through the
survey and examples of questions from each topic sec-
tion. The questions were developed by the team and
guided by the NPT approach illustrated in Table 2. The
survey will be piloted among the research team, nurses
working on the helpline at Breast Cancer Care (n = 4)
and BCNs working in the NHS (n = 2) to test access and
responses before it is distributed. In order to reduce
bias, these nurses will be excluded from completing the
survey and future studies.
This study has strong patient and public representa-
tion. Patient (EB) and Breast Cancer Care (KS) represen-
tatives are co-applicant and collaborator, respectively,
and involved in all substantive study matters. EB has sig-
nificant experience in patient involvement with research
and her insight has complemented the clinical and re-
search expertise of the research team in shaping the
study design.
To develop an audit trail, a record of the data collec-
tion process will be kept throughout the study, including
the selection of the purposive sample for Phase 2.
Phase 2: qualitative interviews
Phase 2 will address objectives 3 and 4 but will also be
grounded in the quantitative results from the first phase,
allowing us to explore and elaborate further on areas of
importance to the overall study.
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Table 2 Use of the normalisation process theory (NPT) topic guide for interview/survey questions
NPT component Example question topics
Coherence
Differentiation
How a set of practice differs from each other
1. The relationship between knowing FoR is an area of concern and
identifying how a new intervention aligns with everyday practice
2. The worth attributed to introducing a FoR intervention
3. Is the intervention easy to describe?
4. Is it different from other interventions?
5. Is there a shared sense of purpose to address FoR among women with
breast cancer?
6. Who would the intervention benefit (thinking more broadly)?
Interview: Whose responsibility is it to discuss FoR?
Is there a shared sense of purpose to address FoR among breast cancer
patients?
How do you think the Mini-AFTER differs to your current method of
assessing patients for FoR
7. Are the benefits likely to be valued by women with breast cancer?
8. Will an intervention fit with the overall goals and activity of the
organisation where the BCN works? Interview: Can you envisage the
Mini-AFTER changing your practice?
Communal specification
Working together to build a shared understanding of the aims,
objectives and benefits of a way of working
Individual specification
Understanding specific tasks and responsibilities around a set of
practice
Internationalisation
Understanding the value, benefit and importance of a set of practices
Cognitive participation
Initiation
A core problem and whether or not key participants are driving it
forward
1. Are BCNs likely to think it is a good idea?
2. Can they see the point of the intervention easily?
Interview: Would you be willing to invest time to attain competence?
3. What kind of skills do BCNs have when dealing with FoR now? Survey:
See Table 2 ver2
4. Will they be prepared to invest time, energy and work in it? Survey:
See Table 2 ver2
This includes:
• Training – examples giving in the survey
• Attaining competence to deliver intervention
• Time to deliver intervention
• Invest in changing practice environment
Enrolment
May need to organise or reorganise themselves – rethinking
relationships
Legitimisation
The belief that an individual can make a contribution
Activation
Identify and define the actions and procedures required to sustain a
new practice
Collective action
Interactional workability
Work people do with each other and the other elements of their
practices to enable them to operationalise it
1. How will providing a specific intervention affect the work of the BCN?
Interview: How would Mini-AFTER impact your workload
Interview: Would Mini-AFTER promote or impede your work?
2. Do they think it would promote or impede their work?
3. What effect will it have on the support they offer to women?
4. Do they think it would change the patient/BCN relationship?
5. Is the work compatible with their existing work practices?
Survey: Questions understanding current working practices
6. How would the addition of an intervention impact on their workload
and that of their colleagues?
7. What impact will there be on resources such as time?
8. How does it fit with the overall goals of their organisation/wider policy
agenda?
Relational integration
The knowledge that participants have to build accountability and
mental confidence in the new intervention
Skill set workability
Allocation of work – who gets to do work in the trial
Contextual integration
Allocation of resources to ensure the intervention can be fully executed
in practice
Reflexive monitoring
Systematisation
Individuals may seek to determine how effective and useful it is for
them and others
1. Perceptions of benefit to patients or staff
2. What may be required to make the intervention workable in practice?
3. When would be an appropriate time to review the intervention?
4. Do they perceive issues associated with recruitment?
Communal appraisal
Participants together (formally and informally) to evaluate the worth of
a set of practices – Is it working?
Individual approval
Work experientially as individuals, its effects on them and the context
(an intervention that complicates and demands workload may well
have low uptake even if beneficial to patient)
Reconfiguration
Modifying or redefining a practice to make it workable in practice
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Phase 2 sampling and recruitment
The final survey question will invite participants to
take part in a 40-min telephone interview. Depending
on the number of participants agreeing to be inter-
viewed, and following analysis of the data from phase
1, a purposive sampling matrix will be developed. If
numbers allow, two demographic factors such as age,
number of years qualified, years in current post or
level of educational attainment will be combined with
sub-groups based on the answers to the following two
key questions which may predict willingness to use
the Mini-AFTER intervention:
 How is the issue of FoR generally raised? (I always raise
a discussion vs. I only discuss FoR if the patient raises it)
 How comfortable are you discussing FoR with your
patients? (Extremely comfortable vs. Not at all
comfortable)
To achieve the planned matrix and reach data satur-
ation, an overall sample size of 20 will be required.
Prior to interview, an information pack about the Mini-
AFTER intervention will be sent to each selected partici-
pant. This pack will be made up of a participant informa-
tion sheet re-iterating the eligibility criteria, an online
presentation and extracts from the Mini-AFTER manual.
Interviews will be digitally audio recorded and conducted
over the phone by ES.
Interviews will explore BCNs’ views on the import-
ance of addressing FoR in their clinical consultations,
and how the Mini-AFTER intervention could be suc-
cessfully integrated in practice. Phase 2 will also pro-
vide valuable information regarding the design and
perceived feasibility of a future RCT, including the
following domains [40]:
 Eligibility—who (people affected by breast cancer)
will participate in the trial?
Table 3 Survey structure and example questions
Section Example questions Question type
1. Consent • Do you consent to taking
part in this survey?
• Multiple choicea
2. About you • No. of years working with
people affected by breast
cancer?
• How many breast care
nurses work on your team?
• Approx. what proportion of
your role is spent in the
following areas?
• Multiple choice
• Multiple choice
• Scaleb
3. About the patients
you meet with
breast cancer
• What psychological care
interventions do you
provide to patients with
breast cancer?
• Multiple choice
FoR definition provided
• In your opinion, what
proportion of your patients
experience FoR at a
moderate level? At a severe
level?
• Multiple choice
4. About the work
you do
• Approx. what proportion of
patients do you discuss
FoR with?
• How is the issue of FoR
generally raised? (I always
raise a discussion on FoR vs.
I only discuss FoR if the
patient raises it)
• In your experience, what
factors trigger FoR in a
breast cancer patient?
• What barriers do you
encounter using assessment
tools in clinical practice?
• Multiple choice
• Scale
• Freetextc
• Freetext
4. About the support
within your team
• What kind of formal
support do you receive to
fulfil your role?
• How would you rate the
support you get from your
team when helping patients
deal with psychological
issues? (Extremely supportive
vs. Not at all supportive)
• How would you rate the
formal support you receive
to fulfil your role?
•
Multiple answerd
• Scale
• Scale
5. About your
preferred support
• Have you received training
to deal specifically with the
area of FoR?
• Multiple choice
Brief explanation of the Mini-
AFTER intervention provided
• If you were offered a one-day
training course to implement
the Mini-AFTER intervention,
would you accept it?
• Multiple choice
6. About other
support services
you use
• If you identify a patient with
moderate FoR, which of the
following services do you refer
them to? With severe FoR?
• How do you decide which
service to refer your patient
to when they have FoR?
• Multiple answer
• Freetext
Table 3 Survey structure and example questions (Continued)
7. Follow-up Explanation of Phase 2 of the
study provided
• Would you be willing to
take part in a telephone
interview?
• Would you be interested in
delivering the Mini-AFTER
intervention in a future
study?
• Multiple choice
• Multiple choice
aMultiple choice questions allow respondents to pick just one answer from a
list of pre-defined answers
bScale questions ask respondents whether they agree or disagree with a
number of statements, to rate items on a scale, or to rank items in order
of importance
cFreetext questions allow respondents to type their answers in their
own words
dMultiple answer questions allow respondents to pick more than one answer
from a list of pre-defined answers
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 Recruitment—how will participants be recruited into
the trial?
 Setting—where will the trial be conducted?
 Organisation—what training and resources will be
needed to deliver Mini-AFTER?
 Delivery—how should Mini-AFTER be delivered?
Table 2 illustrates how the interviews questions will be
guided by NPT and provides examples of questions for
each NPT component.
Validity of interview data
To ensure a consistent interview style is used with all
interview participants, ES will be the sole interviewer.
Direct anonymised quotations will be used to illustrate
findings in any future publications, presentations or re-
ports. Double coding and utilisation of NVivo’s coding
comparison query [41] on 25% of the transcripts will en-
sure consistency and rigour across the whole of the data.
Data analysis
The survey data will be collected, coded and entered
into SPSS 22 [42]. Descriptive statistics will be used to
summarise the sample characteristics and responses to
questions. Multiple responses from the same centre will
be controlled for using a clustering approach.
Descriptive analysis of cross-sectional data will be re-
ported to understand how FoR is currently identified and
addressed in breast cancer patients. Associations will be ex-
amined to investigate variation in these responses according
to self-reported training level, experience and service envir-
onment. Barriers to formal assessment and systematic
intervention of FoR in clinical practice will be investigated.
We will use conventional random intercept/slope regres-
sion models with continuous and binary-dependent vari-
ables using suitable procedures in STATA (xtmixed and
xtmelogit). We will perform tests using these approaches to
determine if a multi-level approach is required. That is, the
two procedures xtmixed2 (for continuous response data)
and xtmelogit2 (for categorical data response data) will pro-
vide a likelihood-ratio statistic to indicate if variance within
clusters (i.e. the BCNs from the same cancer units) is sig-
nificant. To estimate these multi-level models the ‘marginal
likelihood’ has to be estimated using approximate methods
[43]. This approach uses an adaptive quadrature procedure
which enables efficient solutions to be obtained and re-
duced computation time. A sensitivity analysis will be per-
formed to determine the appropriate number of integration
points to obtain the most precise estimation.
Audio recordings from interviews will be transcribed
verbatim, and all identifiable information will be removed
from the transcripts. Framework analysis will guide the
analysis of the qualitative data via a five-step process: (1)
familiarisation with the data; (2) identifying a thematic
framework based on emerging themes or issues in the
data; (3) indexing the data in relation to specific themes;
(4) charting the data based on the indexed themes; and (5)
mapping and interpretation of the data to analyse the key
characteristics in the charts (35). All members of the re-
search team will be involved in at least one step in the
process to ensure both researchers and lay representatives
contribute their expertise at all stages of the study. How-
ever, ES, DF, SC and JA will be involved in all steps.
Coding of the data will be informed by the four main
components of NPT (coherence, cognitive participation,
collective action and reflexive monitoring, Table 2), but
will also provide enough flexibility for any new themes
that may emerge. Double coding will be employed on
25% of the transcripts to ensure any bias in the inter-
pretation of the data is highlighted. Qualitative data will
be coded and managed using NVivo 10 software [41].
Following analysis of the two sets of data, the research
team will integrate the results to reflect the outcomes of
the entire study. Firstly, the quantitative results will be
interpreted to answer objectives 1 and 2. Secondly, the
qualitative findings will enable the phase 1 data to be
further clarified by explaining the statistical results and
addressing detail for objectives 3 and 4. The final stage
will be to discuss and group the findings from both sets
of data to the NPT framework and feasibility domains to
ensure the decision about how, or indeed, whether a lar-
ger trial of the Mini-AFTER intervention could be devel-
oped, ultimately leading to its implementation in
practice, is achieved.
Discussion
The prevalence of FoR and the major impact it has on
breast cancer survivors’ quality of life, psychological
state and use of healthcare services leads to the need for
interventions to be developed to support breast cancer
patients with both severe and moderate levels of FoR.
There are a number of interventions being designed and
tested [14, 15, 44, 45]; however, there is no routinely
available intervention in practice to help support people
with moderate FoR following treatment for cancer. In-
deed there is evidence that some health professionals are
not managing the issue of FoR even when it is brought
to their attention [1]. This has the potential to harm
breast cancer survivors as well as contribute to an in-
creased use of healthcare services in an attempt to seek
ways to cope with their fear [7, 46]. Delivery of a nurse-
led telephone intervention to address FoR could not only
relieve some of the pressure on healthcare services for
follow-up cancer care, but also better serve the psycho-
logical needs of breast cancer survivors.
This study has been designed to provide an overview
(Phase 1) as well as an in-depth insight (Phase 2) into how
FoR is currently being managed in practice, and what
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factors will contribute to the successful implementation of
the Mini-AFTER telephone intervention. Use of NPT will
inform specific aspects of the implementation of this
intervention, such as whether it would promote or impede
BCNs’ work, what impact it would have on their resources
and how it would fit with the overall goals of their organ-
isation/wider policy agenda. Findings will also provide in-
formation to inform the development of an RCT to test
the effectiveness of the Mini-AFTER intervention.
Limitations
The study may be limited by low response rates. We are
relying on BCNs opening their email from Breast Cancer
Care and reading the contents. With the function of auto-
matic sifting of email, we may find that some BCNs are
not contacted through this route. The use of reminders
may mitigate against this. Another limitation is that we
are accessing BCNs through a single route rather than dir-
ectly through their organisations. Although the Breast
Cancer Care Nursing Network is the most comprehensive
database of BCNs working in the UK, and the most com-
prehensive route to accessing BCNs across the country,
the research team will raise awareness of the work among
BCN through hospital and regional BCN networks.
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